We are international
trials TEXT SIZE   

Understanding Pomalyst®
(pomalidomide) capsules

The U.S. Food and Drug Administration (FDA) approved Pomalyst® (pomalidomide) on February 8, 2013, to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.


1 Comment

In Italia quando sarà introdotto? non ho pototo avere notizie in merito, mia moglie dal 2005 è affetta da MM residtente. Grazie

Leave a comment

 related articles